prazosin hydrochloride

Generic: prazosin hydrochloride

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name prazosin hydrochloride
Generic Name prazosin hydrochloride
Labeler aphena pharma solutions - tennessee, llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

prazosin hydrochloride 2 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 71610-694
Product ID 71610-694_8c268130-91fd-4e37-831d-e4410398666b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214608
Listing Expiration 2026-12-31
Marketing Start 2023-01-17

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71610694
Hyphenated Format 71610-694

Supplemental Identifiers

RxCUI
312593 312594
UNII
X0Z7454B90

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name prazosin hydrochloride (source: ndc)
Generic Name prazosin hydrochloride (source: ndc)
Application Number ANDA214608 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (71610-694-30)
  • 60 CAPSULE in 1 BOTTLE (71610-694-53)
  • 90 CAPSULE in 1 BOTTLE (71610-694-60)
  • 180 CAPSULE in 1 BOTTLE (71610-694-80)
source: ndc

Packages (4)

Ingredients (1)

prazosin hydrochloride (2 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "8c268130-91fd-4e37-831d-e4410398666b", "openfda": {"unii": ["X0Z7454B90"], "rxcui": ["312593", "312594"], "spl_set_id": ["d33bb132-1b5f-44a2-bc42-e9201cb6566a"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (71610-694-30)", "package_ndc": "71610-694-30", "marketing_start_date": "20230317"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (71610-694-53)", "package_ndc": "71610-694-53", "marketing_start_date": "20230317"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (71610-694-60)", "package_ndc": "71610-694-60", "marketing_start_date": "20230317"}, {"sample": false, "description": "180 CAPSULE in 1 BOTTLE (71610-694-80)", "package_ndc": "71610-694-80", "marketing_start_date": "20230317"}], "brand_name": "Prazosin Hydrochloride", "product_id": "71610-694_8c268130-91fd-4e37-831d-e4410398666b", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "71610-694", "generic_name": "Prazosin Hydrochloride", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Prazosin Hydrochloride", "active_ingredients": [{"name": "PRAZOSIN HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA214608", "marketing_category": "ANDA", "marketing_start_date": "20230117", "listing_expiration_date": "20261231"}